Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19

The clinical study conducted by researchers from Oxford University (UK) showed that the administration of the steroid - dexamethasone, can reduce mortality in severe COVID-19 patients receiving oxygen therapy.

http://www.ox.ac.uk/news/2020-06-16-dexamethasone-reduces-death-hospitalised-patients-severe-respiratory-complications